BioLineRx was born from the opportunity to source innovative compounds and advance them forward to improve the way we treat diseases. While there is no shortage of excellent scientific ideas and molecules all around us, ideas that linger on a lab bench do little to serve the patients who need them. With focused expertise in drug development and now in commercialization, BioLineRx is in the important position to propel the best of those ideas beyond the bench and all the way to the bedside, ensuring that life-changing therapies reach their full potential and get to patients in need.

Our growing pipeline places particular emphasis on identifying and developing best-in-class treatments for cancer and rare diseases. We chose these areas because we believe we can make a meaningful difference to both patients and caregivers by offering effective therapeutic options that address unmet needs to improve the treatment process and therapeutic outcomes.

I’ve never been prouder to be part of the driven and tight-knit team at BioLineRx. We’re united in our entrepreneurial spirit, pushing ourselves and each other every day to find creative solutions to hard problems. The culture we are building positions us to make a tremendous impact on patients' lives and makes us a strong partner for drug developers not just in Israel, but around the world. Together, we are making the smart bets that we hope will result in game-changing, best-in-class therapeutics for patients with certain cancers and rare diseases, taking the best ideas all the way to the finish line.

Philip Serlin

Chief Executive Officer